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 Receptor-regulated class I phosphoinositide 
3 – kinases (PI3Ks) are lipid kinases that produce 
phosphatidylinositol-3,4,5-trisphosphate (PIP 3 ) 
and phosphatidylinositol-3,4-biphosphate (PIP 2 ) 
at the plasma membrane. These lipids act as 
second messengers by recruiting proteins con-
taining pleckstrin homology (PH) domains to 
cell membranes, thereby initiating various cell 
responses. The PI3Ks are classifi ed as class I A 
and I B , according to their mode of activation. 
Class I A PI3Ks are activated downstream of 
tyrosine (Tyr) kinase – associated receptors ( 1, 2 ), 
whereas class I B is activated by G protein – coupled 
receptors (GPCRs), which include the chemo-
kine receptors ( 3 ). Class I B PI3K binds to G pro-
teins ( 4 ): it has only one catalytic subunit (p110  ), 
which is expressed mainly in leukocytes ( 5 ), 
and two putative regulatory subunits (p101 and 
p87PIKAP) ( 5 – 7 ). 
 T cells are activated after TCR ligation. Tyr 
kinases are the most proximal mediators in TCR 
signaling: lymphocyte-specifi c Tyr kinase (Lck) 
phosphorylates Tyr residues in the immuno-
receptor Tyr-based activation motifs (ITAMs) 
present in each of the TCR-associated CD3 
chains. Once phosphorylated, the ITAMs act 
as docking sites, recruiting   -associated protein 
(ZAP70) to the activated TCR near activated 
Lck, which then phosphorylates and activates 
ZAP70. ZAP70 in turn phosphorylates the adap-
tor molecules Src homology 2 (SH2) domain –
 containing leukocyte protein of 76 kD and 
linker for activation of T cells. The linker for 
activation of T cells and SH2 domain – containing 
leukocyte protein of 76 kD signaling complexes 
activate the guanine nucleotide exchange fac-
tor Vav, which then activates RAS-related C3 
 botulinum substrate 1 (Rac1) and actin reorga-
nization ( 8 ). F-actin polymerization at the TCR 
cell – cell contact site stabilizes the interaction 
between the T cell and the APC ( 9 ). TCR en-
gagement also leads to PI3K activation at the 
immunological synapse (IS), which induces trans-
location of protein kinase B (PKB) to the plasma 
membrane ( 10, 11 ). TCR stimulation also triggers 
recruitment of G  q/11 -coupled chemo kine re-
ceptors to the IS ( 12 ), which cooperate in T 
cell activation. 
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 Class I phosphoinositide 3 – kinases (PI3Ks) constitute a family of enzymes that generates 
3-phosphorylated polyphosphoinositides at the cell membrane after stimulation of protein 
tyrosine (Tyr) kinase – associated receptors or G protein – coupled receptors (GPCRs). The class I 
PI3Ks are divided into two types: class I A p85/p110 heterodimers, which are activated by Tyr 
kinases, and the class I B p110  isoform, which is activated by GPCR. Although the T cell recep-
tor (TCR) is a protein Tyr kinase – associated receptor, p110  deletion affects TCR-induced 
T cell stimulation. We examined whether the TCR activates p110  , as well as the consequences 
of interfering with p110  expression or function for T cell activation. We found that after TCR 
ligation, p110  interacts with G  q/11 , lymphocyte-specifi c Tyr kinase, and   -associated protein. 
TCR stimulation activates p110  , which affects 3-phosphorylated polyphosphoinositide levels 
at the immunological synapse. We show that TCR-stimulated p110  controls RAS-related C3 
botulinum substrate 1 activity, F-actin polarization, and the interaction between T cells and 
antigen-presenting cells, illustrating a crucial role for p110  in TCR-induced T cell activation. 
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Phospho-Tyr – associated PI3K lipid kinase activity was none-
theless reduced in p110   − / −  compared with p110  +/ −  T cells 
at all times tested ( Fig. 2 C ). TCR cross-linking thus activates 
p110  , which associates with Tyr kinases. 
 Inactive p110  prevents PIP 3 accumulation at the IS 
 PIP 3 concentrates at the T cell – APC IS during T cell activa-
tion ( 10, 11 ). We examined whether p110  was concen-
trated at the IS after TCR stimulation, which could contribute 
to PIP 3 production. We transiently transfected Jurkat T cells 
with p110  -GFP ( Fig. 3 A , unstimulated). After incubation 
of cells with anti-CD3 – plus anti-CD28 – coated beads, p110  -
GFP localized in the cytosol near the bead contact area but 
did not concentrate at the IS ( Fig. 3 A ). It was thus possible 
that TCR stimulation aff ected p110  activation but not 
p110  localization. 
 To determine whether p110  contributes to PIP 3 produc-
tion at the IS, we transfected Jurkat T cells with a 3  -polyphos-
phoinositide – specifi c probe composed of the PKB-PH domain 
fused to GFP (GFP – PKB-PH), which binds PIP 3 and PIP 2 with 
 T cell activation is not regulated by the TCR alone: the 
CD4, CD8, and CD28 coreceptors complement the TCR-
induced signals. p85  , the regulatory subunit of class I A PI3K, 
is recruited to the TCR complex by CD3  or CD28, or via 
TCR-interacting molecule (TRIM) ( 13 – 15 ). Moreover, de-
letion of the class I A isoform p110  as well as p85  defects 
interferes with T cell activation, particularly in the CD4 + T 
cell compartment ( 16, 17 ). p110  defi ciency also results in T 
cell activation defects ( 18, 19 ). Nonetheless, it is currently 
not known whether the TCR activates p110  , nor by what 
mechanism it might do so. 
 In this paper, we report p110  activation by TCR cross-
linking. p110  interacts with G  q/11 , Lck, and ZAP70, and by 
modulating Rac1 activity, regulates F-actin polymerization. 
As a consequence, p110  aff ects the interaction between T cells 
and APCs, and regulates T cell activation. 
 RESULTS 
 Reduced in vitro proliferation and expansion of p110  -
defi cient T cells 
 p110  -defi cient T cells have a diminished anti-CD3 pro-
liferative response, which is partially rescued by CD28 co-
stimulation; this defect has been linked to suboptimal IL-2 
production ( 18 ). We tested whether addition of exogenous 
IL-2 augmented TCR-induced proliferation in p110   − / −  T 
cells. Addition of 20 U/ml IL-2 increased CD3- and CD3/
CD28-induced proliferation in p110   − / −  and p110  +/ −  T cells 
but did not completely rescue the p110   − / −  proliferation de-
fect ( Fig. 1 A ). Expansion of purifi ed p110   − / −  T cells after 
TCR-induced stimulation was impaired during long time 
periods after stimulation, even in the presence of exogenous 
IL-2 ( Fig. 1 B ). Impaired TCR-induced proliferation in 
p110   − / −  T cells must therefore be caused not only by re-
duced IL-2 levels but also by other TCR-linked defects. 
 Reduction of TCR-induced proliferation was similar in pu-
rifi ed CD4 + ( Fig. 1 C ) and CD8 + ( Fig. 1 D ) T cells. 
 p110  is activated by TCR engagement 
 To determine whether p110  is activated by the TCR, we 
measured p110  lipid kinase activity after TCR complex 
cross-linking in purifi ed WT CD3 + , CD4 + , and CD8 + mouse 
T cells. CD3 + cells showed transient induction of p110  
 activity, with two peaks at 1 – 3.5 min and at 15 – 30 min after 
activation (with anti-CD3 plus anti-CD28 antibody;  Fig. 2 A ). 
We found a similar two-peak p110  induction profi le in 
CD4 + T cells, whereas a slower and more maintained single 
p110  activity peak was detected in CD8 + cells ( Fig. 2 B ). 
The two-peak profi le was also observed using Jurkat CD4 + T 
cells (not depicted). 
 We also purifi ed p110   − / −  and p110  +/ −  mouse spleen T 
cells, activated them using anti-CD3 antibody, and isolated 
CD3- or Tyr kinase – associated proteins by immunoprecipi-
tation. CD3-associated PI3K lipid kinase activity, which includes 
class I A isoforms ( 13 ), was similar in p110  +/ −  and p110   − / −  
T cells, with a reduction only at late time points ( Fig. 2 C ). 
 Figure 1.  Impaired in vitro proliferation of p110   − / −  T cells. 
(A) Peripheral T cells (CD3 + ) were purifi ed from p110   − / −  and p110  +/ −  mice 
and activated in wells coated with anti-CD3 or anti-CD3 plus anti-CD28, 
alone or with 10 U/ml IL-2. Proliferation was determined at 48 h. Means  ± 
SD are shown for at least three experiments. *, P  ≤ 0.05; **, P  ≤ 0.01. (B) For 
long-term in vitro expansion, p110   − / −  and p110  +/ −  peripheral T cells were 
activated in anti-CD3 – coated wells (day 0) for 24 h; at day 1, cells were 
removed from antibody and 10 U/ml IL-2 was added. The total cell number 
was counted daily. Means  ± SD are shown for three experiments (P  ≤ 0.01). 
(C and D) Proliferation of purifi ed CD4 + (C) or CD8 + (D) T cells from p110   − / −  
and p110  +/ −  mice, as in A. *, P  ≤ 0.05; **, P  ≤ 0.01 . NA, not activated.
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coupled chemokine receptor recruitment to the IS ( 12 ). p110  
binds to G  q/11 and is activated by G  q/11 ( 4 ) after TCR cross-
linking in complex with Tyr-phosphorylated proteins ( Fig. 2 ). 
 We analyzed whether TCR stimulation induced p110  
association to G  q/11 or to Tyr kinases (Lck and ZAP70). We 
activated CXCR4-transfected Jurkat T cells by TCR cross-
linking, using anti-CD3 antibodies for various time periods. 
To determine p110  association, we immunoprecipitated Lck, 
ZAP70, and G  q/11 and examined associated p110  in Western 
blots. TCR stimulation induced p110  association in all cases: 
maximum complexed protein was observed for ZAP70 and 
G  q/11 at 1 – 3.5 min and for Lck at 15 min after stimulation ( Fig. 
4 A ). We tested for the presence of p110  , G  q/11 , and Lck in 
complex with ZAP70. Immunoprecipitation of p110  , G  q/11 , 
and Lck showed transient ZAP70 association, with maximum 
complex formation at 1 – 3.5 min for p110  and G  q/11 ; maxi-
mum Lck association to ZAP70 was found at 15 min after stim-
ulation ( Fig. 4 A ). To defi ne whether this complex involves 
chemokine receptors, we immuno precipitated CXCR4 and 
examined associated proteins in Western blots. CXCR4 asso-
ciation with p110  was sustained, as in a previous report ( 5 ). 
TCR activation moderately enhanced CXCR4 association 
to G  q/11 and induced a remarkable association to ZAP70 at 
15 min ( Fig. 4 B ), confi rming previous observations ( 12, 21 ). 
similar affi  nity. We used the membrane-linked GFP-G   1 plus 
G   2 proteins as a specifi city control. In Jurkat T cells, which lack 
phosphatase and tensin homologue and SH2 domain – con-
taining inositol phosphatase expression, GFP – PKB-PH is 
found at the cell membrane ( Fig. 3 B , top, unstimulated) ( 20 ). 
Incubation with anti-CD3 – plus anti-CD28 – coated beads 
nonetheless induced GFP – PKB-PH redistribution to the IS 
( Fig. 3 B , top, stimulated), confi rming previous reports ( 10, 11 ). 
This redistribution was specifi c, as we found no GFP-G   1 
 redistribution after contact with anti-CD3 – plus anti-CD28 –
 coated beads ( Fig. 3 B , bottom). 
 To determine the potential contribution of p110  to PIP 3 
relocalization at the IS, we cotransfected Jurkat T cells with 
GFP – PKB-PH and either p110  WT or an inactive form of 
p110  (p110  − KR). Cell incubation with anti-CD3 – plus anti-
CD28 – coated beads induced GFP – PKB-PH redistribution to 
the IS in WT p110  -expressing cells ( Fig. 3 C , bottom), but not 
in those bearing the inactive p110  − KR form ( Fig. 3 C , top). 
This suggests a role for p110  in PIP 3 localization at the IS. 
 p110  associates to Lck and ZAP70 after TCR engagement 
 Ligand binding to CXC chemokine receptor (CXCR) 4 
induces its association with the TCR, followed by ZAP70 
activation ( 21 ). Conversely, TCR stimulation induces G  q/11 -
 Figure 2.  p110  is activated by TCR engagement. (A) Purifi ed T cells from WT mice were activated with anti-CD3 plus anti-CD28 for different times. 
p110  was immunoprecipitated from total cell lysate, and its lipid kinase activity was determined in vitro. Lipids were resolved by TLC and visualized by 
autoradiography. Anti-p110  was used in Western blots to control equal amounts of p110  in the different extracts. The histogram represents the x-fold 
increase (means  ± SD) of the PIP 3 signal (quantitated using ImageJ) at different time points (t) compared with that obtained at t = 0. (B) Lipid kinase 
activity as in A was determined in purifi ed CD4 + and CD8 + T cells from WT mice (means  ± SD). (C) Purifi ed T cells from p110   − / −  and p110  +/ −  spleens were 
activated using anti-CD3 for different times, and the CD3- or Tyr kinase – associated protein fractions were immunoprecipitated. CD3- and Tyr kinase –
 associated PI3K lipid kinase activity was determined by ELISA. Means  ± SD are shown for three different experiments. *, P  ≤ 0.05; **, P  ≤ 0.01.  on
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persistent than in Jurkat cells, especially in CD8 + T cells, in 
which the complexes declined slowly. These results show 
that TCR stimulation provokes in CD4 + primary T cells rapid 
formation (1 – 3.5 min) of a complex that includes p110  , 
G  q/11 Lck, and ZAP70, which would correlate with the fi rst 
p110  activation peak observed in these cells and in whole 
CD3 + populations ( Fig. 2 ). In CD8 + T cells, the complex in-
duced by TCR ligation appeared and declined more slowly, 
correlating with p110  activation in these cells. In addition, 
in CD3 + and CD4 + T cells, G  q/11 association to p110  ( Fig. 4, 
C and D ) and to Zap 70 (not depicted) increased again at 
15 min. This observation refl ects formation of a complex 
 including p110  , G  q/11 , and Zap 70; this complex may 
include chemokine receptors, as observed in Jurkat cells ( Fig. 4, 
A and B ) and in previous studies ( 12 ). Formation of this com-
plex correlates with the second p110  activity peak induced 
by T cell activation ( Fig. 2 ). 
 T cell signaling downstream of the TCR is impaired 
in p110   − / −  mice 
 To determine whether p110  contributes to TCR-activated 
signaling cascades, we compared activation of Tyr, PKB, and 
mitogen-activated protein kinase (MAPK) in highly purifi ed 
p110  +/ −  and p110   − / −  T cells stimulated with anti-CD3 
alone or with anti-CD28 mAb. Anti – phospho-Tyr Western 
blots of p110   − / −  and p110  +/ −  T cell extracts showed sev-
eral protein bands (25 – 75 kD) with reduced Tyr phosphoryl-
ation after CD3 stimulation alone or with CD28 ( Fig. 5 A ). 
Similarly, although the anti – phospho-PKB signal was sub-
stantially increased in p110  +/ −  T cells, activation was lower 
in p110   − / −  T cells ( Fig. 5 B ). Anti – phospho-p44/42 MAPK 
analysis showed increased p44/42 MAPK phosphorylation 
in p110  +/ −  T cells after TCR stimulation alone or with 
anti-CD28; this was signifi cantly impaired in p110   − / −  T cells 
( Fig. 5 C ), concurring with p110  involvement in MAPK 
activity ( 22 ). Purifi ed CD4 + and CD8 + T cells gave con-
sistent results in Western blot analyses (unpublished data). 
The data indicate a broad eff ect of p110  deletion on TCR 
downstream signals, including activation of Tyr kinases, PKB, 
and MAPK. 
 Impaired Rac activity in p110  -defi cient mice 
 This overall defect in TCR-induced signaling pathways in 
the absence of p110  led us to test whether p110  has a role in 
IS formation and/or maintenance. Because PI3K regulates Rac 
activity ( 23 ), Rac regulates actin polymerization, and poly-
merized actin is required for synapse stability ( 24 ), we postulated 
that p110  could contribute to T cell activation by regulating 
Rac activity and, thus, actin polymerization. 
 Purifi ed T cells from p110  +/ −  and p110   − / −  mice were 
rested in serum-free medium to reduce basal Rac activation 
levels, then activated by TCR cross-linking for varying pe-
riods. Cells were lysed in GST-FISH buff er, and total protein 
lysate was tested in a Rac pulldown assays ( 25 ). We observed 
a lower and delayed induction of Rac activity in p110   − / −  
than in p110  +/ −  CD3 + cells after TCR ligation ( Fig. 6 A ). 
 These results suggested that T cell stimulation provokes 
rapid formation (1 – 3.5 min) of a complex that includes p110  , 
G  q/11 , and ZAP70 ( Fig. 1 A , histogram), which would cor-
relate with the fi rst p110  activation peak. This fi rst p110  
activation peak after TCR ligation appears independent of 
CXCR4, which associates p110  in a constitutive fashion and 
to ZAP70 only at 15 min. The complex induced by the TCR 
at 15 min involved ZAP70, Lck, CXCR4, and p110  , and 
its formation correlated with the second p110  activity peak. 
 We analyzed whether a similar complex is formed in pri-
mary T cells after TCR cross-linking. We found that p110  
associated with Lck, ZAP70, and G  q/11 in purifi ed mouse 
CD3 + , CD4 + , and CD8 + T cells ( Fig. 4, C – E ). In primary T 
cells, association of p110  to Lck, Zap70, and G  q/11 occurred 
at early time points (1 – 3.5 min) after stimulation and was more 
 Figure 3.  p110  regulates PIP 3 accumulation at the IS. Jurkat T 
cells were transfected with p110  -GFP (A), GFP – PKB-PH (B, top), or GFP-
G   1 plus G   2 (B, bottom), and with a combination of GFP – PKB-PH and 
either p110  -KR (C, top) or p110  -WT (C, bottom). GFP distribution was 
examined by confocal microscopy of live cells. (A) p110  -GFP localized to 
the cell – cell contact site but did not concentrate at the IS. (B) GFP – PKB-
PH is located at the cell membrane and redistributes to the IS after stimu-
lation with anti-CD3 – plus anti-CD28 – coated latex beads (top). As a control, 
GFP-G   1 concentrated at the IS after stimulation (bottom). (C) The PIP 3 
probe GFP – PKB-PH concentrated at the IS in activated cells expressing 
p110  WT (bottom) but not in cells expressing a dominant-negative p110  
form (p110  -KR; top). For each experiment, we analyzed 100 cells. The 
p110  -GFP image is representative of 80% of the cells. The GFP – PKB-PH 
concentration at the IS after stimulation was observed in 77% of the cells, 
whereas the GFP-G   1 image represents  > 95% of the cells. The p110  -KR 
plus GFP – PKB-PH image represents 75% of the cells, and 82% of the cells 
for p110  WT plus GFP – PKB-PH. Bars: 7.5   m. 
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 p110   − / −  T cells show decreased TCR-induced 
actin polymerization 
 TCR-induced T cell activation causes reorganization of the 
actin cytoskeleton, resulting in F-actin polymerization at the 
T cell – APC contact site. As Rac controls actin polymerization, 
we studied potential actin polymerization defects in p110   − / −  
mice. We examined F-actin levels after CD3 cross-linking, 
using GFP-phalloidin to stain F-actin in permeabilized p110   − / −  
and p110  +/ −  T cells. F-actin levels were similar in unstim-
ulated p110   − / −  and p110  +/ −  CD4 + T cells (unpublished 
data). Nonetheless, after TCR stimulation, p110  +/ −  mouse 
CD4 + T cells showed increased F-actin and a less pronounced, 
less sustained increase in p110   − / −  mice. Co-stimulation with 
anti-CD28 did not rescue this defect in CD4 + T cells ( Fig. 
7 A ). Similar defects were observed in p110   − / −  CD8 + T 
cells ( Fig. 7 B ). 
This defective activation was partially compensated at early time 
points by simultaneous anti-CD3 plus anti-CD28 cross-linking, 
but late Rac activation was still defective ( Fig. 6 A ). Using 
 purifi ed anti-CD3 – activated CD4 + and CD8 + T cells, we 
confi rmed the lower TCR induction of Rac activation in both 
populations from p110   − / −  mice ( Fig. 6, B and C ); the defect 
was more remarkable at late time points. In most experiments, 
basal Rac activity levels (time 0) were slightly higher in 
p110   − / −  compared with p110  +/ −  T cells, whereas Western 
blot analysis showed similar Rac protein levels ( Fig. 6, A – C ). 
Analysis of the expression of p110 isoforms showed a moder-
ately higher p110  expression in p110   − / −  than in p110  +/ −  
T cells, which could explain the higher background levels 
in p110   − / −  ( Fig. 6 D ). Despite higher basal activity, TCR-
 triggered Rac activation was defective in p110   − / −  T cells, 
showing that p110  controls Rac activation by the TCR. 
 Figure 4.  p110  interacts with Lck and ZAP70, and is downstream of CD3. Jurkat T cells were transiently transfected with pEGFP-CXCR4. After 
36 h, cells were collected and activated with anti-CD3 mAb for different times. Lysates were immunoprecipitated using anti-Lck, -ZAP70, -G  q/11 , or -p110  
mAb and blotted with anti-p110  (A, top) and anti-ZAP70 (A, bottom) mAb. (B) Lysates were immunoprecipitated with anti-GFP (CXCR4) and blotted with 
anti-p110  , G  q/11 , or ZAP70. (C) Purifi ed T cells (CD3 + ), (D) purifi ed CD4 + T cells, or (E) purifi ed CD8 + T cells from WT mice were collected and activated 
with anti-CD3 mAb for different times. Lysates were immunoprecipitated using anti-Lck, -ZAP70, -G  q/11 , or -p110  mAb and blotted with anti-p110  mAb. 
The histograms represent the x-fold increase in the Western blot signal of p110  associated to Lck, ZAP70, or G  q/11 at different time points (t), 
quantitated using ImageJ and compared with that obtained at t = 0. Arrows indicate maximum complex formation. 
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B cells ( 26 ); B cells were labeled with the green dye PKH67, 
and T cells were labeled with the red dye PKH26. In the ab-
sence of peptide, we observed no 5CC7 Tg CD4 + T cell con-
jugates. After peptide-induced TCR stimulation, the percentage 
of 5CC7 Tg  × p110  +/ −  CD4 + cell conjugates was twofold 
higher than in the same cell subset from p110   − / −  littermates 
( Fig. 8 A ). These data illustrate that a weaker T cell – APC inter-
action occurs in p110   − / −  compared with p110  +/ −  T cells. 
 To confi rm these observations and extend them to CD8 + 
T cells, we purifi ed CD8 + T cells from F5 Tg  × p110   − / −  
and F5 Tg  × p110  +/ −  mice and incubated them with B cells 
from F5 Tg  × p110  +/ −  mice. The TCR expressed on F5TCR 
Tg specifi cally recognizes the infl uenza peptide NP 366 – 374 in 
the MHC class I H-2D b context. After addition of the spe-
cifi c peptide, the percentage of F5 Tg  × p110  +/ −  CD8 + cell 
conjugates was twofold higher than in the same subset from 
p110   − / −  littermates ( Fig. 8 B ), confi rming the role of p110  
in T cell – APC conjugate stabilization. 
 Based on these observations, we predicted that interfer-
ence with endogenous p110  activity in T cells would inhibit 
cell conjugate formation. We transfected Jurkat T cells with 
empty vector, p110  WT, or p110  − KR. At 48 h after trans-
fection, the cells were tested in a conjugate formation assay 
 We also examined whether interference with endogenous 
p110  activity in Jurkat cells aff ected actin polymerization 
after TCR-induced stimulation. Jurkat cells transfected with 
empty vector, p110  WT, or the inactive p110  -KR were 
stimulated with anti-CD3 alone or anti-CD3 plus anti-CD28 
mAb, and FITC-phalloidin staining was measured by fl ow 
cytometry at various times. Control cells showed increased 
F-actin polymerization in both TCR activation protocols, 
which was enhanced by p110  WT and inhibited by p110  -
KR overexpression ( Fig. 7 C ). These results indicate a key role 
for p110  in TCR-induced actin polymerization. 
 T cell – APC conjugate formation is impaired in p110   − / −  
 F-actin polymerization at the TCR cell – cell contact site sta-
bilizes the interaction between the T cell and the APC ( 9 ). 
To study p110  involvement in the maintenance of T cell – APC 
conjugates, we purifi ed primary CD4 + T cells from 5CC7 
transgenic (Tg)  × p110   − / −  and 5CC7 Tg  × p110  +/ −  mice. 
The 5CC7 TCR recognizes pigeon cytochrome c (PCC) 
peptide 88 – 104 in the MHC class II I-E k context. For APCs, we 
purifi ed splenic B cells from 5CC7 Tg  × p110  +/ −  mice. Us-
ing a FACS-based assay, we measured the ability of p110   − / −  
and p110  +/ −  T cells to form conjugates with peptide-pulsed 
 Figure 5.  Impaired signaling downstream of TCR in p110   − / −  mice. Purifi ed peripheral T cells from p110   − / −  and p110  +/ −  mice were stimulated by 
cross-linking with anti-CD3 or anti-CD3 plus anti-CD28 for the times indicated. T cell lysates were resolved in SDS-PAGE, followed by Western blot with 
(A) anti – phospho-Tyr (P-Tyr), (B) anti – phospho-PKB (P-PKB) and anti-PKB, and (C) anti – phospho-p44/42 MAPK (P-MAPK) and anti-p44/42 MAPK 
(MAPK) antibodies; anti-PKB and -MAPK antibodies were used as loading controls, as indicated. The fi gures show one representative blot of at least 
three experiments with similar results. Data from the Western blots were quantifi ed by densitometry using ImageJ software and are reported as the 
x-fold intensity increase compared with t = 0. Dashed lines separate blots for different activation conditions. Histograms represent means  ± SD of three 
(P-PKB and P-ERK) or four (P-Tyr) experiments with similar results (A, P  ≤ 0.01; B, P  ≤ 0.05; C, P  ≤ 0.01). In the P-Tyr blot, numbers indicate molecular 
weight markers (MWM; left). 
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(unpublished data) ( 27 ). p110  might nonetheless have other 
functions in immunocompetent T cells, because T cells lack-
ing p110  have defects in TCR-induced cell activation ( 18 ). 
Moreover, in addition to class I A involvement in T cell activation 
( 16 ), class I B PI3K controls TCR- and pre-TCR – induced 
T cell diff erentiation ( 19 ) as well as memory T cell gen eration 
( 28, 29 ). p110  might thus collaborate with class I A PI3K to 
activate T cells. The partial maintenance of T cell function in 
the absence of class I A PI3K ( 30 ) and the remarkable thymocyte 
diff erentiation defect in both class I A p110  - and class I B p110  -
defi cient mice ( 31, 32 ) indicate a role for p110  in TCR-
induced T cell activation. These results imply an important 
function for p110  in TCR-mediated T cell activation. 
 We show that p110  is activated by TCR ligation. p110  
was known to be activated in response to GPCR by direct bind-
ing to G protein    subunits ( 4, 33 ), whereas the link between 
p110  and the TCR was less clear. Class I A PI3K p85  binds 
the TCR CD3  chain and to the CD28 coreceptor ( 13, 14 ); 
using staphylococcal enterotoxin E (SEE) – loaded Raji cells. 
Although p110  WT enhanced conjugate formation, the pro-
portion of conjugates was reduced in p110  -KR – transfected 
Jurkat cells ( Fig. 8 C ). These observations show that p110  
regulates conjugate formation between T cells and APC. 
 DISCUSSION 
 Mice lacking p110  have a partial defect in T cell diff erentiation 
and activation. We sought to determine how the TCR regulates 
p110  activity in T cells. In this study, we show that p110  is 
activated by the TCR, which induces association of p110  with 
G  q/11 , and with the ZAP70 and Lck Tyr kinases. p110  reg-
ulates Rac activation and in turn F-actin polarization, which 
stabilizes conjugate formation between T cells and APCs. 
 p110  has a central role in neutrophil and macrophage 
migration to infl ammatory sites ( 18 ). Despite p110  regulation 
of thymocyte exit to the periphery ( 19 ), however, this enzyme 
is less important for chemokine-induced T cell migration 
 Figure 6.  p110  controls Rac activation downstream of the TCR. (A) Rac activity assay in purifi ed p110   − / −  and p110  +/ −  peripheral T cells. T cells were 
stimulated with soluble anti-CD3 antibody or anti-CD3 plus anti-CD28 antibody. Extracts were analyzed in pulldown assays using Gex2T-CRIB Pak1 as bait. 
Rac-GTP and total Rac cell content were examined by Western blotting. One representative analysis is shown out of three performed. Data from Western 
blots were quantifi ed by densitometry and are reported as the x-fold intensity of the GTP-Rac1 signal compared with that observed at t = 0. Data represent 
means  ± SD of three experiments. (B) Rac activity assay in purifi ed CD4 + p110   − / −  and p110  +/ −  T cells as in A. (C) Rac activity assay in purifi ed CD8 + p110   − / −  
and p110  +/ −  T cells as in A. (D) Representative immunoblots of class I A p110  , p110  , and p110  subunits in purifi ed p110   − / −  and p110  +/ −  CD3 + peripheral T 
cells. PKB and Rac Western blots illustrate equal loading. Dashed lines separate blots for different mouse phenotypes. MWM, molecular weight markers. 
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and the TCR, and uses the TCR ITAM domains and ZAP70 
for signal transduction ( 21 ). Another study showed physical 
association between CD3 	 and G  q/11 , and that CD3 ligation 
induces GTP exchange within G  q/11 ( 35 ); this suggested that 
after TCR engagement, G  q/11 participates in pathways that me-
diate CD3 Tyr phosphorylation. Our results indicate that 
TCR stimulation induces p110  association to G  q/11 , 
ZAP70, and Lck, all of which are critically involved in TCR 
activation. In CXCR4-transfected Jurkat T cells, p110  
activation shows two peaks, the first of which correlates 
with p110  association with G  q/11 , Lck, and ZAP70 but 
not with increased CXCR4 association to p110  or ZAP70. 
The second peak correlates with enhanced p110  associa-
tion with Lck, ZAP70, and CXCR4. p110  activation is thus 
initially CXCR4 independent and is linked to the direct 
p110  association with G  q/11 and Tyr kinases. Formation of 
the p110  – G  q/11 – Lck – ZAP70 complex could bring p110  
into proximity with the IS, enhancing local PIP 3 production. 
Similar complexes could also enhance PIP 3 production at the 
IS in CD4 + and CD8 + peripheral T cells, because the com-
plex formation is faster but less sustained in CD4 + than in 
CD8 + T cells. 
 APC activation of T cells begins with formation of the IS, 
a highly organized complex of surface receptors, intracellular 
signaling molecules, and F-actin at the T cell contact site 
( 36, 37 ). TCR cross-linking enhances PIP 3 production, which 
concentrates at the IS in T cells; PI3K activation then induces 
PKB translocation to the plasma membrane ( 10, 11 ). We 
confi rm PIP 3 accumulation at the T cell contact site with the 
APC; p110  did not localize exclusively to the IS, but was 
activated within the synapse when it complexed with CD3-
associated Tyr kinases. GFP – PKB-PH localization experiments 
showed that expression of a dominant-negative p110  reduced 
PIP 3 concentration at the synapse. These results indicate that 
p110  activity regulates PIP 3 content at the IS. 
 Actin cytoskeleton rearrangement is critical at several points 
in TCR-induced cell activation ( 9, 37 ), including IS formation 
and maintenance ( 38 – 40 ). Studies in a variety of cell types iden-
tify Rac as a key modulator of F-actin polymerization ( 41 ). 
Cytoskeletal reorganization by GPCR depends on p110  as 
well as on Rac ( 42 ). p110  participates in Rac1 activation after 
CC chemokine ligand 5 stimulation of macrophages ( 43 ). Rac 
also controls actin polymerization in both CD4 + and CD8 + 
T cells ( 39, 44 ). TCR ligation activates p110  , which in turn 
regulates Rac activity, because interference with p110  re-
duced and delayed Rac activation. These Rac activation defects 
explain the reduced F-actin levels in p110   − / −  T cells compared 
with controls after TCR cross-linking. In addition, actin did not 
polymerize in PI3K  -KR – transfected Jurkat cells. Our results 
thus demonstrate a critical role for p110  in TCR-induced, 
Rac-mediated actin polymerization. 
 p110   − / −  CD4 + and CD8 + T cells also showed reduced 
T cell – APC conjugate formation, suggesting that T cell –
 APC interaction is weaker in p110   − / −  than in p110  +/ −  T 
cells. Accordingly, the proportion of T cell – APC conjugates 
was clearly reduced in PI3K  -KR – transfected Jurkat cells, 
PI3K activity is also associated with CD3 	 after TCR en-
gagement ( 34 ). We show that class I B p110  is downstream 
of TCR signaling, and that TCR cross-linking with anti-CD3 
antibodies activates p110  and induces its association with Lck, 
ZAP70, and G  q/11 . This association may be direct or medi-
ated via an intermediate adaptor. During T cell stimulation 
by APCs, chemokine receptors couple to G  q/11 proteins, which 
are recruited to the IS on T cells; chemokine receptor trap-
ping at the synapse enhances T cell activation ( 12 ). The CXC 
chemokine ligand 12 stimulates physical association of CXCR4 
 Figure 7.  p110  regulates TCR-induced actin polymerization. 
(A and B) CD4 + (A) or CD8 + (B) purifi ed T cells from p110   − / −  and p110  +/ −  
mice were stimulated with soluble anti-CD3 or anti-CD3 plus anti-CD28 
mAb for the times indicated. Phalloidin staining was determined by fl ow 
cytometry and is expressed as the increase in mean fl uorescence intensity 
over that observed at t = 0. Means  ± SD are shown for three independent 
experiments. (C) p110  interferes with actin polymerization in Jurkat T cells. 
Jurkat T cells were transfected with vector alone, p110  , or p110  -KR 
(48 h) and activated with soluble anti-CD3 or anti-CD3 plus anti-CD28 
mAb for the times indicated. Phalloidin staining was determined by 
flow cytometry and is expressed as in A. Means  ± SD are shown for 
three independent experiments. 
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facility; all animal studies were approved by the Ethics Committee for Animal 
Experimentation at the CNB in compliance with European Union legislation. 
 Primary cells.  Spleen and lymph node cell suspensions were T cell enriched by 
depletion of B cells using mouse pan B (B220) Dynabeads (Invitrogen), followed 
by incubation for 2 h at 37 ° C on plastic plates to eliminate adherent cells, or us-
ing the CD3 negative isolation kits (Invitrogen); T cells were 90 – 95% CD3 + by 
FACS analysis (Epics XL-MCL; Beckman Coulter). For CD4 + or CD8 + cells, 
T cell – enriched suspensions were depleted of CD8 + or CD4 + cells using 
Dynabeads or using CD4 or CD8 negative isolation kits (Invitrogen). When B 
cells were used as APCs, T cells were depleted from suspensions with mouse pan 
T (Thy1.2) Dynabeads (Invitrogen). For conjugation assays, F5 Tg mouse B cells 
were pulsed overnight at 37 ° C with 2   g/ml of infl uenza peptide NP 366 – 374 , or 
5CC7 Tg mouse B cells were pulsed with 2   g/ml PCC peptide 88 – 104 . 
 Cloning and expression constructs.  The construct encoding the PKB-
PH domain in the pEGFP-C1 vector was a gift of J. Downward (Cancer 
Research, London, UK). The PI3K  -GFP construct, a C-terminal GFP-
tagged PI3K  , was donated by R. Wetzker (Friedrich-Schiller University, 
Jena, Germany). We also used p110  WT and p110  -KR (a dominant-neg-
ative PI3K  form) cloned in the pcDNA3 vector, pEGFP-CXCR4 (a gift of 
M. Mellado, CNB, Madrid, Spain), pCEFL EGFP G  1, and PCEFL G  2 
(both gifts from J.S. Gutkind, National Institutes of Health, Bethesda, MD). 
 Cell lines and transfections.  Jurkat T cells were maintained in DMEM 
(BioWhittaker) with 10% FBS (Sigma-Aldrich), 2 mM glutamine, 50   M 
2-mercaptoethanol, and 100 U/ml penicillin/streptomycin. 1.5  × 10 7 
cells in 400   l of complete medium were transfected by electroporation 
of 25   g DNA using a GenePulser (270 V, 950   F; Bio-Rad Laboratories). 
Cells were immediately transferred to 10 ml of growth medium and as-
sayed 24 – 48 h later, when FACS or Western blot analyses showed maxi-
mum expression. 
 The Raji lymphoblastoid cell line was maintained in RPMI 1640 (Bio-
Whittaker) supplemented as described in the previous paragraph. For conju-
gation assays, 10 7 Raji cells per milliliter were resuspended in serum-free 
RPMI and incubated with 1   g/ml SEE (Toxin Technology) for 2 h at 
37 ° C, with mixing every 20 min. 
 T cell activation.  For biochemical analysis, immunoprecipitation assays, 
and actin polymerization assays, we incubated purifi ed mouse T cells, Jurkat 
T cells, or Jurkat transfectants for 2 h in DMEM with 0.1% BSA (fraction V low 
showing that p110  regulates conjugate formation between 
T cells and APCs. 
 Most of the defects described in this paper aff ect p110   − / −  
CD4 + and CD8 + T cells similarly. This is not surprising, as 
p110  formed a similar complex in both CD4 + and CD8 + 
cells after TCR activation ( Fig. 4 ). Nonetheless, induction of 
p110  complexes in WT CD8 + T cells was slower, probably 
refl ecting a lesser CD8 + T cell dependence on p110  for 
early T cell activation. In accordance with these observations, 
we found a less pronounced defect in TCR activation-induced 
actin polymerization in p110   − / −  CD8 + than in CD4 + cells. 
Despite a requirement for Vav1 in both lineages, a point mu-
tation in the Vav1 PH domain selectively aff ects TCR-induced 
proliferation of CD4 + but not CD8 + T cells, suggesting diff er-
ential wiring of TCR signaling pathways in these two cell types 
( 45 ), a possibility that might also be supported by our data. 
 In this paper, we demonstrate that p110  is activated after 
TCR cross-linking and binds G  q/11 , Lck, and ZAP70. Acti-
vated p110  regulates Rac activation and actin polymerization, 
which governs the stability of the IS ( 9, 37, 38 ). We show that 
p110  deletion aff ects the activation of many downstream path-
ways after TCR cross-linking, as well as the interaction between 
T cells and APCs, which could explain the defective activation 
of p110   − / −  T cells. Collectively these observations clarify the 
p110  activation mechanism and mode of action in the control 
of T cell activation. 
 MATERIALS AND METHODS 
 Mice.  p110   − / −  mice were previously described ( 46 ) and were maintained 
in heterozygosis. 5CC7 TCR (V  3V  11) and F5 TCR (V  11V  4) Tg 
mice ( 47, 48 ) were provided by M. Davis (Howard Hughes Medical Institute, 
Stanford, CA) and D. Kioussis (Medical Research Council, London, UK), 
respectively. F5TCR Tg mice were crossed with p110   − / −  mice; 5CC7 
TCR Tg mice were crossed with p110   − / −  mice on the C57BL/6 back-
ground (a gift from Serono International, Geneva, Switzerland). Off spring 
were analyzed by PCR and fl ow cytometry to confi rm TCR and MHC. Mice 
were bred and maintained in specifi c pathogen-free conditions in our animal 
 Figure 8.  p110  regulates cell conjugate formation. (A) p110   − / −  CD4 + T cells showed impaired TCR-induced conjugate formation. Purifi ed CD4 + T 
cells were obtained from 5CC7 Tg  × p110   − / −  and 5CC7 Tg  × p110  +/ −  spleens. For APCs, B cells were purifi ed from 5CC7 Tg  × p110  +/ −  spleens. T cells 
were labeled with PKH67 (green) and APCs were labeled with PKH26 (red), and B cells were pulsed with PCC peptide 88 – 104 . Conjugate formation, as deter-
mined by fl ow cytometry, is represented as the T cell fraction that shifted into two-color conjugates. Means  ± SD are shown for three independent experi-
ments. (B) TCR-induced conjugate formation was impaired in p110   − / −  CD8 + T cells. Purifi ed CD8 + T cells were obtained from F5 Tg  × p110   − / −  and F5 Tg  × 
p110  +/ −  spleens; B cells (APCs) were purifi ed from F5 Tg  × p110  +/ −  spleens. Cells were labeled as in A, and B cells were pulsed with the infl uenza peptide 
NP 366 – 374 . Conjugate formation was determined as in A. (C) p110  interferes with conjugate formation in Jurkat T cells. Jurkat cells were transfected with 
vector alone, p110  , or p110  -KR (48 h) and mixed with SEE-loaded Raji B cells for the times indicated. Conjugate formation was determined as in A. 
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endotoxin; Sigma-Aldrich), after which cells were washed and resuspended 
in serum-free medium. For activation, 5 – 10  × 10 6 cells were incubated in 
1.5-ml Eppendorf tubes with 1   g/ml of soluble anti-CD3 or 1   g/ml of 
anti-CD3 plus anti-CD28 for 15 min on ice, and were then cross-linked with 
1   g/ml of secondary antibody for 10 min on ice, followed by incubation at 
37 ° C for various time periods, as shown in the fi gures. Cells were collected 
and processed for analysis. For proliferation and expansion assays, plastic 
wells were coated with 5   g/ml anti-CD3 or 1.25   g/ml anti-CD3 plus anti-
CD28. Antibodies used were hamster anti – mouse CD3 	 (145-2C11) and CD28 
(37.51), mouse anti – human CD3 	 (UCHT1) and CD28 (CD28.2), mouse 
anti – Armenian and  – Syrian hamster IgG1 (G94-56), mouse anti – Armenian 
hamster IgG (G192-1; all obtained from BD Biosciences), and rabbit anti – mouse 
IgG (Fc  fragment specifi c; Jackson ImmunoResearch Laboratories). 
 Proliferation and expansion assays.  Plastic wells were coated as described 
in the previous section with anti-CD3 or anti-CD3 plus anti-CD28, and 
cells were added to plates, followed by 20 U/ml IL-2. After 48 h, 1   Ci 
[ 3 H]thymidine was added, and incorporation was measured 12 h later. Splenic 
T cells from p110  +/ −  and p110   − / −  mice were cultured with platebound 
anti-CD3 for 48 h and then in fl asks with 20 U/ml IL-2. Cells were counted at 
the times indicated in the fi gures. 
 Lipid kinase activity assays.  5 – 10  × 10 6 purifi ed mouse T cells were in-
cubated with 0.1% BSA, washed, and resuspended in serum-free medium, 
then activated with hamster anti-CD3 mAb and cross-linked with secondary 
antibodies, as described. Cells were lysed in digitonin lysis buff er (1% digitonin, 
300 mM NaCl, 2 mM EDTA, 20 mM triethanolamine [pH 8], 20% glycerol, 
1   g/ml leupeptin, 1   g/ml aprotinin, 5 mM NaF, 1 mM orthovanadate, 1 mM 
phenylmethanesulphonylfl uoride, and 2 nM okadaic acid) and immuno-
precipitated (100   g) with 3   l anti-CD3 or 3   l anti – phospho-Tyr (4G10; 
Millipore), followed by protein A – sepharose for 1 h at 4 ° C. Precipitates were 
washed three times with 50 mM Tris-HCl, pH 7.4, and tested by ELISA to 
detect PI3K activity (Echelon). 
 Alternatively, precipitates were used as substrate for a lipid kinase reac-
tion. To start, 20   l PIP 2 (0.5 mg/ml in 10 mM Hepes, 0.1 mM EDTA, pH 7) 
and 5   l of the phosphorylation mixture (10 mM Hepes, 0.1 mM EDTA 
[pH 7], 100 mM MgCl 2 , 10   Ci [ 32 P]ATP, 200 mM ATP) were added to the 
pellets at room temperature for 10 min. To terminate the reaction, we added 
100   l of 1-M HCl, followed by 200   l chloroform/methanol (1:1). The 
phases were separated by centrifugation, and 100   l of the lower organic phase 
were washed with 80   l methanol/HCl (1:1). Lipids were dried, resuspended 
in 10   l chloroform/methanol (2:1), resolved by TLC in chloroform/
methanol/NH 4 OH (9:7:2), and visualized by autoradiography. 
 Statistical analyses.  Statistical analyses were performed using StatView 512+ 
software (SAS Institute). Gel bands and fl uorescence intensity were quanti-
tated with ImageJ software (National Institutes of Health). 
 Online supplemental material.  Information on Western blots, Immuno-
precipitation assays, the Rac activation assay, the FACS-based conjugate forma-
tion assay, the Actin polymerization assay, and Stimulation with antibody-coated 
beads and immunofl uorescence are available in Supplemental materials and 
methods. Online supplemental material is available at http://www.jem
.org/cgi/content/full/jem.20070366/DC1. 
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